Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
72% male) from 804 sites in 41 countries with overweight or obesity (BMI of 27 kg/m or higher) who were enrolled and treated with weekly injections of semaglutide (at doses slowly titrated to 2.4 mg at week 16) or placebo
Semaglutide appears to be different
Semaglutide (Wegovy, Ozempic) Regulates appetite and reduces cravings Helps control portion sizes and supports sustained energy Proven to help with significant weight reduction Tirzepatide (Mounjaro) Dual-action medication to regulate appetite and metabolism It may offer enhanced weight loss compared to other medications It helps balance blood sugar levels and promotes fat metabolism GLP-1 Therapy Controls appetite naturally, without stimulant side effects Reduces challenges of traditional dieting It helps create a healthier relationship with food Retatrutide Advanced therapy targeting multiple weight regulation pathways Provides comprehensive metabolic support for enhanced results Our experts will help determine which treatment or combination is right for you
NCT07035093
